- Home
- SCLX vs FURY Comparison
SCLX vs FURY Comparison
Compare SCLX & FURY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- FURY
- Stock Information
- Founded
- SCLX 2011
- FURY 2008
- Country
- SCLX United States
- FURY Canada
- Employees
- SCLX N/A
- FURY N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- FURY Precious Metals
- Sector
- SCLX Health Care
- FURY Basic Materials
- Exchange
- SCLX Nasdaq
- FURY Nasdaq
- Market Cap
- SCLX 72.5M
- FURY 59.1M
- IPO Year
- SCLX N/A
- FURY N/A
- Fundamental
- Price
- SCLX $0.45
- FURY $0.37
- Analyst Decision
- SCLX Strong Buy
- FURY Strong Buy
- Analyst Count
- SCLX 3
- FURY 1
- Target Price
- SCLX $11.33
- FURY $1.10
- AVG Volume (30 Days)
- SCLX 184.3K
- FURY 121.7K
- Earning Date
- SCLX 03-11-2025
- FURY 11-12-2024
- Dividend Yield
- SCLX N/A
- FURY N/A
- EPS Growth
- SCLX N/A
- FURY N/A
- EPS
- SCLX N/A
- FURY N/A
- Revenue
- SCLX $55,152,000.00
- FURY N/A
- Revenue This Year
- SCLX $32.77
- FURY N/A
- Revenue Next Year
- SCLX $50.71
- FURY N/A
- P/E Ratio
- SCLX N/A
- FURY N/A
- Revenue Growth
- SCLX 9.41
- FURY N/A
- 52 Week Low
- SCLX $0.38
- FURY $0.32
- 52 Week High
- SCLX $2.63
- FURY $0.59
- Technical
- Relative Strength Index (RSI)
- SCLX 42.08
- FURY 43.79
- Support Level
- SCLX $0.40
- FURY $0.36
- Resistance Level
- SCLX $0.53
- FURY $0.38
- Average True Range (ATR)
- SCLX 0.05
- FURY 0.02
- MACD
- SCLX 0.01
- FURY 0.00
- Stochastic Oscillator
- SCLX 47.59
- FURY 26.32
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About FURY Fury Gold Mines Limited
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.